Insulin Production: Harnessing Microbial Power

The question asks about the microorganism used to produce genetically engineered human insulin. This process is a cornerstone of modern biotechnology and a vital advancement in treating diabetes.

Understanding Genetically Engineered Insulin

Diabetes mellitus is a condition where the body either doesn't produce enough insulin or can't effectively use the insulin it produces. Insulin is a hormone crucial for regulating blood sugar levels. Traditionally, insulin for medical use was extracted from the pancreases of cows and pigs. However, animal-sourced insulin could cause allergic reactions and had limitations in supply and purity.

Genetic engineering allows scientists to produce human insulin in large quantities using microorganisms. This is achieved through recombinant DNA technology. The process involves:

• Identifying and isolating the human gene that codes for insulin.
• Inserting this human insulin gene into a suitable vector (like a plasmid).
• Introducing the recombinant vector into a host organism (a microorganism).
• Culturing the host organism under specific conditions, enabling it to replicate the gene and produce human insulin.
• Extracting and purifying the produced insulin.

Why E. coli is the Preferred Host

The bacterium Escherichia coli (E. coli) is the most commonly used host for producing genetically engineered human insulin. This is due to several key advantages:

• Well-Characterized Genome: E. coli is one of the most extensively studied organisms, making genetic manipulation easier and more predictable.
• Rapid Growth: It reproduces very quickly, allowing for rapid production of large quantities of the desired protein.
• Ease of Cultivation: It can be grown easily and cost-effectively in large fermenters under controlled conditions.
• High Yields: Genetic modifications can enhance its ability to produce significant amounts of human insulin.
• Proven Track Record: It was the first organism successfully used to produce recombinant human insulin (marketed as Humulin), proving its efficacy and safety for this application.

Evaluating Other Options

The other options provided are generally not the primary choice for manufacturing genetically engineered human insulin:

• Rhizopus: This is a type of fungus (bread mold). While fungi are used in biotechnology for producing various substances (like enzymes or citric acid), E. coli is preferred for insulin production due to efficiency and historical success.
• Pseudomonas: This is a genus of bacteria. While some species have biotechnological applications, E. coli remains the standard for recombinant insulin production.
• Ashbya gossypii: This is another fungus, notable for its ability to produce riboflavin (Vitamin B2). It is not typically used for insulin synthesis.

Therefore, E. coli stands out as the key microorganism in the large-scale manufacturing of genetically engineered human insulin, revolutionizing diabetes care.